Advertisement
Screener

Q/C Technologies, Inc. (QCLS) Accounts Payable, Related Parties, Current

2.8 / 5 stars · 68/120 Roast Me

Q/C Technologies, Inc. Accounts Payable, Related Parties, Current

Q/C Technologies, Inc. (QCLS) had Accounts Payable, Related Parties, Current of $696.93 thousand as of 2020-12-31, per its 10-K filed 2022-03-31.

Discontinued › Notes › Payables and Accruals

us-gaap:AccountsPayableRelatedPartiesCurrent · last filed 2022-03-31

  • 2020-12-31: Accounts Payable, Related Parties, Current $696.93K; Accounts Payable, Related Parties, Current as first filed $477.04K.
  • 2018-09-30: Accounts Payable, Related Parties, Current $47.19K.
  • 2018-06-30: Accounts Payable, Related Parties, Current $16.70K.
  • 2018-03-31: Accounts Payable, Related Parties, Current $19.00K.
Period endAccounts Payable, Related Parties, CurrentAccounts Payable, Related Parties, Current as first filed
2020-12-31$696.93K
10-K · filed 2022-03-31
$477.04K
10-Q · filed 2021-11-12
2018-09-30$47.19K
10-Q · filed 2018-11-14
2018-06-30$16.70K
10-Q · filed 2018-08-14
2018-03-31$19.00K
10-Q · filed 2018-07-13
2017-12-31$39.82K
10-Q · filed 2018-11-14
2017-09-30$20.25K
10-Q/A · filed 2018-07-13
2017-06-30$33.91K
10-Q/A · filed 2018-07-13
2017-03-31$95.88K
10-Q · filed 2017-05-15
2016-12-31$234.07K
10-Q/A · filed 2018-07-13
2016-09-30$59.67K
10-Q · filed 2016-11-14
2014-09-30$0.00
10-Q · filed 2014-11-13
2014-06-30$0.00
10-Q · filed 2014-08-12
2014-03-31$0.00
10-Q · filed 2014-05-14
2013-12-31$6.59K
10-K · filed 2015-03-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
BIOMERICA INC (BMRA)United States$0.011B
VOLITIONRX LTD (VNRX)$0.003B-0.64
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92